Characterization of novel airway submucosal gland cell models for cystic fibrosis studies

Cellular Physiology and Biochemistry

Volumn 15, Issue 6, 2005, Pages 251-262

  Da Paula, Ana Carina ^a   Ramalho, Anabela S ^a   Farinha, Carlos M ^a,b   Cheung, Judy ^c   Maurisse, Rosalie ^c   Gruenert, Dieter C ^c,d,e   Ousingsawat, Jiraporn ^f   Kunzelmann, Karl ^f   Amaral, Margarida D ^a,b  

^a NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^b UNIVERSITY OF LISBON   (Portugal)

^c CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Airway cell line; Calu 3; CF cellular model; CFTR; Cystic fibrosis; Epithelial cells; Submucosal gland

Indexed keywords

CHLORIDE CHANNEL;

ARTICLE; CELL CULTURE; CELL FUNCTION; CELL LINE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTIC FIBROSIS; ELECTROPHYSIOLOGY; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN CELL; MOLECULAR MODEL; MUCUS GLAND; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM;

EID: 22544474185     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087235     Document Type: Article

References (73)

1. McNicholas CM, Guggino WB, Schwiebert EM, Hebert SC, Giebisch G, Egan ME: Sensitivity of a renal K+ channel (ROMK2) to the inhibitory sulfonylurea compound glibenclamide is enhanced by coexpression with the ATP-binding cassette transporter cystic fibrosis transmembrane regulator. Proc Natl Acad Sci U S A 1996;93:8083-8088.
2. Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M, Tsui LC: Identification of the cystic fibrosis gene: genetic analysis. Science 1989;245:1073-1080.
3. Kunzelmann K: The cystic fibrosis transmembrane conductance regulator and its function in epithelial transport. Rev Physiol Biochem Pharmacol 1999;137:1-70.
4. Riordan JR, Rommens JM, Kerem B-S, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou J-L, Drumm ML, Iannuzzi MC, Collins FS, Tsui L-C: Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245:1066-1073.
5. Tsui L-C, al. e: Cystic Fibro¡sis Mutation Database. In, http://www.genet.sickkids.on.ca/cftr/, 2004.
6. Consortium TCFGA: World-wide survey of ΔF508 mutation - Report from Cystic Fibrosis Genetic Analysis Consortium. Am J Hum Genet 1990;47.
7. Tsui L-C: The spectrum of cystic fibrosis mutations. Trends in Genet 1992;8:392-398.
8. Collins FS: Cystic fibrosis: molecular biology and therapeutic implications. Science 1992;256:774-783.
9. Aitken ML, Fiel SB: Cystic fibrosis. J Clin Invest 1993;91:225-234.
10. Widdicombe JH, Welsh MJ, Finkbeiner WE: Cystic fibrosis decreases the apical membrane chloride permeability of monolayers cultured from cells of tracheal epithelium. Proc Natl Acad Sci USA 1985;82:6167-6171.
11. Puchelle E, Gaillard D, Ploton D, Hinnrasky J, Fuchey C, Boutterin MC, Jacquot J, Dreyer D, Pavirani A, Dalemans W: Differential localization of the cystic fibrosis transmembrane conductance regulator in normal and cystic fibrosis airway epithelium. Am J Respir Cell Mol Biol 1992;7:485-491.
12. Marino CR, Matovcik LM, Gorelick FS, Cohn JA: Localization of the cystic fibrosis transmembrane conductance regulator in pancreas. J Clin Invest 1991;88:712-716.
13. Denning GM, Ostedgaard LS, Welsh MJ: Abnormal localization of cystic fibrosis transmembrane conductance regulator in primary cultures of cystic fibrosis airway epithelia. J Cell Biol 1992;118:551-559.
14. Crawford I, Maloney PC, Zeitlin PL, Guggino WB, Hyde SC, Turley H, Gatter KC, Harris A, Higgins CF: Immunocytochemical localization of the cystic fibrosis gene product CFTR. Proc Natl Acad Sci U S A 1991;88:9262-9266.
15. Trapnell BC, Chu CS, Paakko PK, Banks TC, Yoshimura K, Ferrans VJ, Chernick MS, Crystal RG: Expression of the cystic fibrosis transmembrane conductance regulator gene in the respiratory tract of normal individuals and individuals with cystic fibrosis. Proc Natl Acad Sci U S A 1991;88:6565-6569.
16. Trezise AE, Buchwald M: In vivo cell-specific expression of the cystic fibrosis transmembrane conductance regulator. Nature 1991;353:434-437.
17. Jacquot J, Puchelle E, Hinnrasky J, Fuchey C, Bettinger C, Spilmont C, Bonnet N, Dieterle A, Dreyer D, Pavirani A, et al.: Localization of the cystic fibrosis transmembrane conductance regulator in airway secretory glands. Eur Respir J 1993;6:169-176.
18. Engelhardt JF, Yankaskas JR, Ernst SA, Yang Y, Marino CR, Boucher RC, Cohn JA, Wilson JM: Submucosal glands are the predominant site of CFTR expression in the human bronchus. Nature Genet 1992;2:240-248.
19. Doucet L, Mendes F, Montier T, Delepine P, Penque D, Ferec C, Amaral MD: Applicability of different antibodies for the immunohistochemical localization of CFTR in respiratory and intestinal tissues of human and murine origin. J Histochem Cytochem 2003;51:1191-1199.
20. Ballard ST, Inglis SK: Liquid secretion properties of airway submucosal glands. J Physiol 2004;556:1-10.
21. Jiang C, Finkbeiner WE, Widdicombe JH, Miller SS: Fluid transport across cultures of human tracheal glands is altered in cystic fibrosis. J Physiol 1997;501 (Pt 3):637-647.
22. Gruenert DC, Basbaum CB, Widdicombe JH: Long-term culture of normal and cystic fibrosis epithelial cells grown under serum-free conditions. In Vitro Cell Dev Biol 1990;26:411-418.
23. Kalin N, Claass A, Sommer M, Puchelle E, Tummler B: DeltaF508 CFTR protein expression in tissues from patients with cystic fibrosis. J Clin Invest 1999;103:1379-1389.
24. Widdicombe JH, Coleman DL, Finkbeiner WE, Tuet I: Electrical properties of monolayers cultured from cells of human tracheal mucosa. J Appl Physiol 1985;58:1729-1735.
25. Yankaskas JR, Cotton CU, Knowles MR, Gatzy JT, Boucher RC: Culture of human nasal epithelial cells on collagen matrix supports. Am Rev Respir Dis 1985;132:1281-1287.
26. Yankaskas JR, Knowles MR, Gatzy JT, Boucher RC: Persistence of abnormal chloride ion permeability in cystic fibrosis nasal epithelial cells in heterologous culture. Lancet 1985;1:954-956.
27. Gruenert DC, Finkbeiner WE, Widdicombe JH: Culture and transformation of human airway epithelial cells. Am J Physiol 1995;268:L347-360.
28. Gruenert DC, Willems M, Cassiman JJ, Frizzell RA: Established cell lines used in cystic fibrosis research. J Cyst Fibros 2004;3 Suppl 2:191-196.
29. Cozens AL, Yezzi MJ, Chin L, Simon EM, Friend DS, Gruenert DC: Chloride ion transport in transformed normal and cystic fibrosis epithelial cells. Adv Exp Med Biol 1991;290:187-194; discussion 194-186.
30. Cozens AL, Yezzi MJ, Chin L, Simon EM, Finkbeiner WE, Wagner JA, Gruenert DC: Characterization of immortal cystic fibrosis tracheobronchial gland epithelial cells. Proc Natl Acad Sci U S A 1992;89:5171-5175.
31. Cozens AL, Yezzi MJ, Yamaya M, Steiger D, Wagner JA, Garber SS, Chin L, Simon EM, Cutting GR, Gardner P, et al.: A transformed human epithelial cell line that retains tight junctions post crisis. In Vitro Cell Dev Biol 1992;28A:735-744.
32. Cozens AL, Yezzi MJ, Kunzelmann K, Ohrui T, Chin L, Eng K, Finkbeiner WE, Widdicombe JH, Gruenert DC: CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am J Respir Cell Mol Biol 1994;10:38-47.
33. Jefferson DM, Valentich JD, Marini FC, Grubman SA, Iannuzzi MC, Dorkin HL, Li M, Klinger KW, Welsh MJ: Expression of normal and cystic fibrosis phenotypes by continuous airway epithelial cell lines. Am J Physiol 1990;259:L496-L505.
34. Jetten AM, Yankaskas JR, Stutts MJ, Willumsen NJ, Boucher RC: Persistence of abnormal chloride conductance regulation in transformed cystic fibrosis epithelia. Science 1989;244:1472-1475.
35. Kunzelmann K, Schwiebert EM, Zeitlin PL, Kuo WL, Stanton BA, Gruenert DC: An immortalized cystic fibrosis tracheal epithelial cell line homozygous for the delta F508 CFTR mutation. Am J Respir Cell Mol Biol 1993;8:522-529.
36. Kunzelmann K, Lei DC, Eng K, Escobar LC, Koslowsky T, Gruenert DC: Epithelial cell specific properties and genetic complementation in a delta F508 cystic fibrosis nasal polyp cell line. In Vitro Cell Dev Biol Anim 1995;31:617-624.
37. Gruenert DC, Basbaum CB, Welsh MJ, Li M, Finkbeiner WE, Nadel JA: Characterization of human tracheal epithelial cells transformed by an origin-defective simian virus 40. Proc Natl Acad Sci U S A 1988;85:5951-5955.
38. Wei X, Eisman R, Xu J, Harsch AD, Mulberg AE, Bevins CL, Glick MC, Scanlin TF: Turnover of the cystic fibrosis transmembrane conductance regulator (CFTR): slow degradation of wild-type and delta F508 CFTR in surface membrane preparations of immortalized airway epithelial cells. J Cell Physiol 1996;168:373-384.
39. Zeitlin PL, Lu L, Rhim J, Cutting G, Stetten G, Kieffer KA, Craig R, Guggino WB: A cystic fibrosis bronchial epithelial cell line: immortalization by adeno-12-SV40 infection. Am J Respir Cell Mol Biol 1991;4:313-319.
40. Schiavi SC, Abdelkader N, Reber S, Pennington S, Narayana R, McPherson JM, Smith AE, Hoppe Ht, Cheng SH: Biosynthetic and growth abnormalities are associated with high-level expression of CFTR in heterologous cells. Am J Physiol 1996;270:C341-351.
41. Stutts MJ, Gabriel SE, Olsen JC, Gatzy JT, O'Connell TL, Price EM, Boucher RC: Functional consequences of heterologous expression of the cystic fibrosis transmembrane conductance regulator in fibroblasts. J Biol Chem 1993;268:20653-20658.
42. Rommens JM, Dho S, Bear CE, Kartner N, Kennedy D, Riordan JR, Tsui LC, Foskett JK: cAMP-inducible chloride conductance in mouse fibroblast lines stably expressing the human cystic fibrosis transmembrane conductance regulator. Proc Natl Acad Sci U S A 1991;88:7500-7504.
43. Kartner N, Hanrahan JW, Jensen TJ, Naismith AL, Sun SZ, Ackerley CA, Reyes EF, Tsui LC, Rommens JM, Bear CE, et al.: Expression of the cystic fibrosis gene in non-epithelial invertebrate cells produces a regulated anion conductance. Cell 1991;64:681-691.
44. Cheng SH, Gregory RJ, Marshall J, Paul S, Souza DW, White GA, O'Riordan CR, Smith AE: Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 1990;63:827-834.
45. Farinha CM, Mendes F, Roxo-Rosa M, Penque D, Amaral MD: A comparison of 14 antibodies for the biochemical detection of the cystic fibrosis transmembrane conductance regulator protein. Mol Cell Probes 2004;18:235-242.
46. Brezillon S, Hamm H, Heilmann M, Schafers HJ, Hinnrasky J, Wagner TO, Puchelle E, Tummler B: Decreased expression of the cystic fibrosis transmembrane conductance regulator protein in remodeled airway epithelium from lung transplanted patients. Hum Pathol 1997;28:944-952.
47. Shen BQ, Finkbeiner WE, Wine JJ, Mrsny RJ, Widdicombe JH: Calu-3: a human airway epithelial cell line that shows cAMP-dependent Cl- secretion. Am J Physiol 1994;266:L493-501.
48. Varga K, Jurkuvenaite A, Wakefield J, Hong JS, Guimbellot JS, Venglarik CJ, Niraj A, Mazur M, Sorscher EJ, Collawn JF, Bebok Z: Efficient intracellular processing of the endogenous cystic fibrosis transmembrane conductance regulator in epithelial cell lines. J Biol Chem 2004;279:22578-22584.
49. Sommerhoff CP, Finkbeiner WE: Human tracheobronchial submucosal gland cells in culture. Am J Respir Cell Mol Biol 1990;2:41-50.
50. Gluzman Y: SV40-transformed simian cells support the replication of early SV40 mutants. Cell 1981;23:175-182.
51. Small MB, Gluzman Y, Ozer HL: Enhanced transformation of human fibroblasts by origin-defective SV40. Nature 1982;296:671-675.
52. Lechner JF, LaVeck MA: A serum-free method for culturing normal human bronchial epithelial cells at clonal density. J Tissue Culture Methods 1985;9:43-48.
53. Ramalho AS, Beck S, Schindelhauer D, Amaral MD: Sequence of CFTR exons present in clones from PAC library RPCIP704. In, The Virtual Repsoitory of Cystic Fibrosis European Network, 2004.
54. Ramalho AS, Beck S, Farinha CM, Clarke LA, Heda GD, Steiner B, Sanz J, Gallati S, Amaral MD, Harris A, Tzetis M: Methods for RNA extraction, cDNA preparation and analysis of CFTR transcripts. J Cyst Fibros 2004;3 Suppl 2:11-15.
55. Amaral MD, Clarke LA, Ramalho AS, Beck S, Broackes-Carter F, Rowntree R, Mouchel N, Williams SH, Harris A, Tzetis M, Steiner B, Sanz J, Gallati S, Nissim-Rafinifa M, Kerem B, Hefferon T, Cutting GR, Goina E, Pagani F: Quantitative methods for the analysis of CFTR transcripts/splicing variants. J Cyst Fibros 2004;3 Suppl 2:17-23.
56. Goncz KK, Kunzelmann K, Xu Z, Gruenert DC: Targeted replacement of normal and mutant CFTR sequences in human airway epithelial cells using DNA fragments. Hum Mol Genet 1998;7:1913-1919.
57. Chalkley G, Harris A: Lymphocyte mRNA as a resource for detection of mutations and polymorphisms in the CF gene. J Med Genet 1991;28:777-780.
58. Ramalho AS, Beck S, Meyer M, Penque D, Cutting GR, Amaral MD: Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis. Am J Respir Cell Mol Biol 2002;27:619-627.
59. Farinha CM, Penque D, Roxo-Rosa M, Lukacs G, Dormer R, McPherson M, Pereira M, Bot AG, Jorna H, Willemsen R, Dejonge H, Heda GD, Marino CR, Fanen P, Hinzpeter A, Lipecka J, Fritsch J, Gentzsch M, Edelman A, Amaral MD: Biochemical methods to assess CFTR expression and membrane localization. J Cyst Fibros 2004;3 Suppl 2:73-77.
60. Mendes F, Farinha CM, Roxo-Rosa M, Fanen P, Edelman A, Dormer R, McPherson M, Davidson H, Puchelle E, De Jonge H, Heda GD, Gentzsch M, Lukacs G, Penque D, Amaral MD: Antibodies for CFTR studies. J Cyst Fibros 2004;3 Suppl 2:69-72.
61. Farinha CM, Nogueira P, Mendes F, Penque D, Amaral MD: The human DnaJ homologue (Hdj)-1/heat-shock protein (Hsp) 40 co-chaperone is required for the in vivo stabilization of the cystic fibrosis transmembrane conductance regulator by Hsp70. Biochem J 2002;366:797-806.
62. Koslowsky T, Hug T, Ecke D, Klein P, Greger R, Gruenert DC, Kunzelmann K: Ca(2+)- and swelling-induced activation of ion conductances in bronchial epithelial cells. Pflugers Arch 1994;428:597-603.
63. Gabriel SE, Davenport SE, Steagall RJ, Vimal V, Carlson T, Rozhon EJ: A novel plant-derived inhibitor of cAMP-mediated fluid and chloride secretion. Am J Physiol 1999;276:G58-63.
64. Kammouni W, Moreau B, Becq F, Saleh A, Pavirani A, Figarella C, Merten MD: A cystic fibrosis tracheal gland cell line, CF-KM4. Correction by adenovirus-mediated CFTR gene transfer Am J Respir Cell Mol Biol 1999;20:684-691.
65. Ramalho AS, Beck S, Penque D, Gonska T, Seydewitz HH, Mall M, Amaral MD: Transcript analysis of the cystic fibrosis splicing mutation 1525-1G>A shows use of multiple alternative splicing sites and suggests a putative role of exonic splicing enhancers. J Med Genet 2003;40:e88.
66. Frischmeyer PA, van Hoof A, O'Donnell K, Guerrerio AL, Parker R, Dietz HC: An mRNA surveillance mechanism that eliminates transcripts lacking termination codons. Science 2002;295:2258-2261.
67. Will K, Dork T, Stuhrmann M, von der Hardt H, Ellemunter H, Tummler B, Schmidtke J: Transcript analysis of CFTR nonsense mutations in lymphocytes and nasal epithelial cells from cystic fibrosis patients. Hum Mutat 1995;5:210-220.
68. Carroll TP, Morales MM, Fulmer SB, Allen SS, Flotte TR, Cutting GR, Guggino WB: Alternate translation initiation codons can create functional forms of cystic fibrosis transmembrane conductance regulator. J Biol Chem 1995;270:11941-11946.
69. - conductance. Am J Physiol 1994;266:L502-L512.
70. Yamaya M, Sekizawa K, Kakuta Y, Ohrui T, Sawai T, Sasaki H: P2u-purinoceptor regulation of chloride secretion in cultured human tracheal submucosal glands. Am J Physiol 1996;270:L979-984.
71. Devor DC, Singh AK, Lambert LC, DeLuca A, Frizzell RA, Bridges RJ: Bicarbonate and chloride secretion in Calu-3 human airway epithelial cells. J Gen Physiol 1999;113:743-760.
72. Tamada T, Hug MJ, Frizzell RA, Bridges RJ: Microelectrode and impedance analysis of anion secretion in Calu-3 cells. Jop 2001;2:219-228.
73. Joo NS, Irokawa T, Wu JV, Robbins RC, Whyte RI, Wine JJ: Absent secretion to vasoactive intestinal peptide in cystic fibrosis airway glands. J Biol Chem 2002;277:50710-50715.